Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

A critical evaluation of validity and utility of translational imaging in pain and analgesia: Utilizing functional imaging to enhance the process.

Upadhyay J, Geber C, Hargreaves R, Birklein F, Borsook D.

Neurosci Biobehav Rev. 2018 Jan;84:407-423. doi: 10.1016/j.neubiorev.2017.08.004. Epub 2017 Aug 12. Review.

PMID:
28807753
2.

Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology.

Kia S, Choy E.

Biomedicines. 2017 May 8;5(2). pii: E20. doi: 10.3390/biomedicines5020020. Review.

3.

Juvenile fibromyalgia in an adolescent patient with sickle cell disease presenting with chronic pain.

Ramprakash S, Fishman D.

BMJ Case Rep. 2015 Oct 1;2015. pii: bcr2015211850. doi: 10.1136/bcr-2015-211850.

4.

Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies.

Del Giorno R, Skaper S, Paladini A, Varrassi G, Coaccioli S.

Pain Ther. 2015 Dec;4(2):169-78. doi: 10.1007/s40122-015-0038-6. Epub 2015 Sep 3.

5.

A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients.

Murakami M, Osada K, Mizuno H, Ochiai T, Alev L, Nishioka K.

Arthritis Res Ther. 2015 Aug 22;17:224. doi: 10.1186/s13075-015-0718-y.

6.

The search for novel analgesics: targets and mechanisms.

Yaksh TL, Woller SA, Ramachandran R, Sorkin LS.

F1000Prime Rep. 2015 May 26;7:56. doi: 10.12703/P7-56. eCollection 2015. Review.

7.

Interest in yoga among fibromyalgia patients: an international internet survey.

Firestone KA, Carson JW, Mist SD, Carson KM, Jones KD.

Int J Yoga Therap. 2014;24:117-24.

8.

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia.

Ellis JJ, Sadosky AB, Ten Eyck LL, Cappelleri JC, Brown CR, Suehs BT, Parsons B.

Clinicoecon Outcomes Res. 2014 Oct 14;6:389-99. doi: 10.2147/CEOR.S66759. eCollection 2014.

9.

Management of fibromyalgia syndrome: review of evidence.

Okifuji A, Hare BD.

Pain Ther. 2013 Dec;2(2):87-104. doi: 10.1007/s40122-013-0016-9. Epub 2013 Sep 21.

10.

Interpreting effect sizes and clinical relevance of pharmacological interventions for fibromyalgia.

Arnold LM, Cappelleri JC, Clair A, Masters ET.

Pain Ther. 2013 Jun;2(1):65-71. doi: 10.1007/s40122-013-0011-1. Epub 2013 Apr 18.

11.

Does increasing steps per day predict improvement in physical function and pain interference in adults with fibromyalgia?

Kaleth AS, Slaven JE, Ang DC.

Arthritis Care Res (Hoboken). 2014 Dec;66(12):1887-94. doi: 10.1002/acr.22398.

12.

Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia.

Spaeth M, Alegre C, Perrot S, Wang Y, Guinta DR, Alvarez-Horine S, Russell I; Sodium Oxybate Fibromyalgia Study Group.

Arthritis Res Ther. 2013 Nov 11;15(6):R185. doi: 10.1186/ar4375.

13.

Extension trial of qigong for fibromyalgia: a quantitative and qualitative study.

Sawynok J, Lynch M, Marcon D.

Evid Based Complement Alternat Med. 2013;2013:726062. doi: 10.1155/2013/726062. Epub 2013 Aug 28.

14.

Duloxetine: a review of its safety and efficacy in the management of fibromyalgia syndrome.

Smith HS, Bracken D, Smith JM.

J Cent Nerv Syst Dis. 2010 Dec 22;2:57-72. doi: 10.4137/JCNSD.S4127. Print 2010.

15.

Complementary and alternative exercise for fibromyalgia: a meta-analysis.

Mist SD, Firestone KA, Jones KD.

J Pain Res. 2013;6:247-60. doi: 10.2147/JPR.S32297. Epub 2013 Mar 27.

16.

Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment.

Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D.

Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. Epub 2012 Nov 4. Erratum in: Pain Res Treat. 2013;2013:960270.

17.

Meeting them where they are: Using the Internet to deliver behavioral medicine interventions for pain.

Rini C, Williams DA, Broderick JE, Keefe FJ.

Transl Behav Med. 2012 Mar;2(1):82-92. doi: 10.1007/s13142-011-0107-2. Review.

18.

Milnacipran for neuropathic pain and fibromyalgia in adults.

Derry S, Gill D, Phillips T, Moore RA.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD008244. doi: 10.1002/14651858.CD008244.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD008244.

19.

Fibromyalgia: a primer for the anesthesia community.

Brummett CM, Clauw DJ.

Curr Opin Anaesthesiol. 2011 Oct;24(5):532-9. doi: 10.1097/ACO.0b013e32834a1091. Review.

20.

Pharmacotherapy for fibromyalgia.

Smith HS, Bracken D, Smith JM.

Front Pharmacol. 2011 Mar 31;2:17. doi: 10.3389/fphar.2011.00017. eCollection 2011.

Supplemental Content

Support Center